5D00

ICD-11 MMS 2026-01

Amyloidosis

Description

Amyloidosis is a vast group of diseases defined by the presence of insoluble protein deposits in tissues. Its diagnosis is based on histological findings. Amyloidoses are classified according to clinical signs and biochemical type of amyloid protein involved. Most amyloidoses are multisystemic, 'generalised' or 'diffuse'. There are a few forms of localised amylosis. The most frequent forms are AL amyloidosis (immunoglobulins), AA (inflammatory), and ATTR (transthyretin accumulation).

Excludes

  • 6D80 – Dementia due to Alzheimer disease

Exclusions from above levels

  • 2B31.2 – histiocytosis X (chronic)
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
  • 5A71.01 – Congenital adrenal hyperplasia
Show allHide
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

  • 5D00.0 – AL amyloidosis
  • 5D00.1 – AA amyloidosis
  • 5D00.2 – Hereditary amyloidosis
  • 5D00.3 – Dialysis-associated amyloidosis
  • 5D00.Y – Other specified amyloidosis
  • 5D00.Z – Amyloidosis, unspecified

Sibling codes

  • 5D01 – Tumour lysis syndrome
  • 5D0Y – Other specified metabolic disorders

Foundation entity

Amyloidosis – http://id.who.int/icd/entity/2078467774

Allowed postcoordination axes

Part of: 05: Endocrine, nutritional or metabolic diseases